NYU Langone Health
Established: 1841
Location: New York, United States
NYU Langone Health
Established: 1841
Location: New York, United States
Alternate Identifiers
ROR ID: https://ror.org/005dvqh91
CrossRef Funder ID: 100006962
ISNI: 0000 0001 2109 4251
WikiData: Q6956114
2 Core Facilities:
1 Service Outside the Institution
1 Consult Outside the Institution
Research Engineering
Transgenics
Cell Culture
Computational - Application Development
Data Visualization
ES Cell Technology (Mouse)
Embryo Cryopreservation & Recovery Services
Image Processing And Analysis
Pipeline Development
R Shiny App DevelopmentAssisted Reproductive Technologies (Rodent IVF, ICSI)
Sperm Cryopreservation
Transgenics
Computational - Application Development
Data Visualization
Image Processing And Analysis
Pipeline Development
R Shiny App Development
Research Engineering
Adam Rubens
550 1st Avenue
New York, NY 10016 - United States
https://nyumc.ilab.agilent.com/sc/5998/research_software_engineering_core
RRID:SCR_023022
The Research Software Engineering (RSE) Core is a resource launched by NYU Langone, based in the Information Technology department in close collaboration with the NYU Grossman School of Medicine. We design, develop, optimize, and customize software to accelerate research.
This facility does not provide services outside its institution
This facility does not consult outside its institution
01/31/2024
Assisted Reproductive Technologies (Rodent IVF, ICSI)
Cell Culture
Embryo Cryopreservation & Recovery Services
ES Cell Technology (Mouse)
Sperm Cryopreservation
Transgenics
Transgenics
Cytometry and Cell Sorting Laboratory Editor
550 First Avenue
New York, NY 10016 - United States of America
https://med.nyu.edu/research/scientific-cores-shared-resources/rodent-genetic-engineering-laboratory
NYU Langone’s Laura and Isaac Perlmutter Cancer Center. Support Grant National Institues of Health/
RRID:RRID:SCR_017925
The Rodent Genetic Engineering Laboratory (RGEL) at NYU Langone Medical applies advanced molecular genetic techniques in rodent models. Experienced at generating novel mutant mouse strains by using gene targeting in embryonic stem cells (ESCs) and by developing novel methods of modifying rodent genomes and assaying genetically modified cells in vivo. Customizes technologies to meet individual project needs, including specialized expertise in use clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein 9 (Cas9) systems and other approaches for direct genome editing in vivo.Services include CRISPR/Cas9,proprietary rapid strain-creation method known as EZ-Mouse Model, tetraploid complementation systems, GEMMs-ESC Speedy Models, regulated gene expression by high-throughput RNA interference assay in mice, safe-harbor knock-in gene editing using Rosa26 and other loci, recombinase-mediated cassette exchange, Inducible Tet-On and Tet-Off Gene Expression Systems, homologous recombination, induced pluripotent stem cells, assisted reproductive technologies, and vitrification systems,production of transgenic mice by pronuclear injection of plasmid DNA or bacterial artificial chromosome DNA and the production of ESC chimeras by blastocyst injection. Production of fully ESC-derived mice by tetraploid complementation, including following, isolating, and manipulating novel ESC lines from existing mouse strains.Offers sperm and embryo cryopreservation and storage technologies for strain preservation and recovery. Highly efficient in vitro fertilization technologies using fresh or cryopreserved sperm are available, facilitating import of novel mouse strains without quarantine and recovery of poorly breeding strains.Offers traditional embryo rederivation technologies for animal import into barrier vivaria through quarantine.
This facility provides services outside its institution
This facility provides consulting outside its institution
06/23/2023